Angiogenesis Imaging

Angiogenesis Imaging: What Can Different Modalities Do?

Thursday, Dec. 2, 3:00 – 4:00 PM

Panel members are reviewing the roles of optical imaging, MRI, CT, PET and ultrasound in angiogenesis imaging and discussing the strengths and weaknesses of various modalities for evaluating angiogenesis and resultant changes with therapy.

Speaker Information:
  • Umar Mahmood, MD, PhD, associate professor, radiology, Harvard Medical School in Boston;
  • Peter L. Choyke, MD, chief, senior clinician, molecular imaging, National Cancer Institute in Bethesda, Md.;
  • Robert F. Mattrey, MD, director, in vivo cellular & molecular imaging program, University of California, San Diego;  
  • Dushyant V. Sahani, MD, clinical instructor, radiology, Massachusetts General Hospital in Boston; and
  • Andrei H. Iagaru, MD, assistant professor, radiology, Stanford University School of Medicine in Calif.

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.